Inserm at a Glance

Published on: 12/07/2021
Reading time: < 1 min

Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.

Chairman and Chief Executive Officer Gilles BlochExecutive Vice President, Strategy Thomas LombèsExecutive Vice President, Administration Damien Rousset12 Regional Delegations9 Theme-Based InstitutesMore than 13,200 scientific publications in 2020 i.e. :15% of French production, all research fields combined38% of publications in the biological and medical fieldsMore than 2,000 active patent families in 2020. Inserm is the :1st European patent applicant in the pharmaceutical sector2nd in the biotechnology category8th French patent applicant, all organizations and sectors combined263 research units40 service units34 clinical investigation centers1st academic organization in biomedical research in Europe2 international mixed units30 foreign laboratories integrated in the Inserm International research projects program10 foreign laboratories integrated into a CNRS-Inserm international research network2 Nobel Prizes Jean Dausset (1980) Françoise Barré-Sinoussi (2008)3 Lasker PrizesEtienne-Emile Baulieu (1989) Pierre Chambon (2004) Alim-Louis Benabid (2014)5,047 civil servants, including 2,144 researchers and 2,903 engineers and technicians3,257 contract staff and temporary workers5,499 university-hospitals and universities staff personnelInitial budget 2021 967.36 M€External resources 32.6%State funding 67.4%

Learn more about Inserm

Governance and organization

About Us

Europe and International

Europe and International
Inserm_FG10869_ProtéomiqueMag49_IAU.png

Good Practices at Inserm

Our Research